Cadila Healthcare Fact Sheet, Cadila Healthcare Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Cadila Healthcare Fact Sheet    (CADIL)


Revealed: How to Claim Bhambwani's 'Fast Profits' Book, Free


Here is the latest financial fact sheet of Cadila Healthcare. For more details, see the Cadila Healthcare quarterly results and Cadila Healthcare share price and chart. For a sector overview, read our pharmaceuticals sector report.

CADILA HEALTHCARE Price History

Price Rs 344.5
Mkt Cap Rs m 352,627
Vol '000 261.0
P/E X 28.4
P/CF X 14.4
EPS (TTM) Rs 12.1
% ch % 1.9
No. of shares m 1,023.74
% ch week % -0.6
% ch 1-mth % 5.5
% ch 12-mth % 30.6
52 week H/L Rs 378.0/206.5
(As on May 29, 2020 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

CADILA HEALTHCARE Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
5-Yr Chart
Click to enlarge
CADILA HEALTHCARE EQUITY SHARE DATA
High Rs1,763454460558432 
Low Rs872305305362306 
Sales per share (Unadj.) Rs422.592.191.6116.3128.6 
Earnings per share (Unadj.) Rs56.219.214.817.918.5 
Diluted earnings per shareRs11.219.214.817.918.5 
Cash flow per share (Unadj.) Rs70.222.018.523.124.4 
Dividends per share (Unadj.) Rs12.003.203.203.503.50 
Adj. dividends per shareRs2.403.203.203.503.50 
Dividend yield (eoy) %0.90.80.80.80.9 
Book value per share (Unadj.) Rs220.855.768.085.4101.5 
Adj. book value per shareRs44.255.768.085.4101.5 
Shares outstanding (eoy) m204.751,023.741,023.741,023.741,023.74 
Bonus/Rights/Conversions  -FV5:1--- 
Price / Sales ratio x3.14.14.24.02.9 
Avg P/E ratio x23.419.825.825.719.9 
P/CF ratio (eoy) x18.817.220.719.915.1 
Price / Book Value ratio x6.06.85.65.43.6 
Dividend payout %21.416.721.619.618.9 
Avg Mkt Cap Rs m269,758388,458391,581470,664378,170 
No. of employees `00013.215.416.911.812.4 
Total wages/salary Rs m12,08512,61615,19818,54521,241 
Avg. sales/employee Rs Th6,564.06,105.05,563.010,072.710,585.0 
Avg. wages/employee Rs Th916.9817.0901.71,569.11,707.8 
Avg. net profit/employee Rs Th873.01,272.1901.51,547.71,526.5 
CADILA HEALTHCARE INCOME DATA
Net Sales Rs m86,51394,26893,765119,049131,656 
Other income Rs m5541,1561,2841,1322,011 
Total revenues Rs m87,06795,42495,049120,181133,667 
Gross profit Rs m17,59923,30519,04428,47529,731 
Depreciation Rs m2,8732,9213,7335,3885,986 
Interest Rs m6795284469111,935 
Profit before tax Rs m14,60121,01216,14923,30823,821 
Minority Interest Rs m-397430338628469 
Prior Period Items Rs m420000 
Extraordinary Inc (Exp) Rs m-104-25-300 
Tax Rs m2,6361,7741,2895,6445,303 
Profit after tax Rs m11,50619,64315,19518,29218,987 
Gross profit margin %20.324.720.323.922.6 
Effective tax rate %18.18.48.024.222.3 
Net profit margin %13.320.816.215.414.4 
CADILA HEALTHCARE BALANCE SHEET DATA
Current assets Rs m40,88742,80460,22382,00584,981 
Current liabilities Rs m29,92134,61053,05860,72073,425 
Net working cap to sales %12.78.77.617.98.8 
Current ratio x1.41.21.11.41.2 
Inventory Days Days6052707375 
Debtors Days Days69688998110 
Net fixed assets Rs m40,52646,98772,98483,703133,493 
Share capital Rs m1,0241,0241,0241,0241,024 
"Free" reserves Rs m44,18455,96868,57686,421102,839 
Net worth Rs m45,20856,99269,60087,445103,863 
Long term debt Rs m11,5048,96424,68425,55139,497 
Total assets Rs m91,342105,506152,207180,653234,831 
Interest coverage x22.540.837.226.613.3 
Debt to equity ratio x0.30.20.40.30.4 
Sales to assets ratio x0.90.90.60.70.6 
Return on assets %13.319.110.310.68.9 
Return on equity %25.534.521.820.918.3 
Return on capital %26.133.318.022.018.3 
Exports to sales %32.547.2000 
Imports to sales %6.26.2000 
Exports (fob) Rs m28,08044,537000 
Imports (cif) Rs m5,3915,838000 
Fx inflow Rs m29,66644,88121,28042,68348,404 
Fx outflow Rs m8,0939,06910,87411,24211,593 
Net fx Rs m21,57335,81210,40631,44136,811 
CADILA HEALTHCARE CASH FLOW
From Operations Rs m 9,936 18,935 13,117 9,193 28,823 
From Investments Rs m -4,647 -8,635 -28,719 -9,737 -57,387 
From Financial Activity Rs m -3,511 -9,348 23,158 515 18,846 
Net Cashflow Rs m 1,778 991 7,556 -29 -7,105 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 74.8%
Foreign collaborators 0.0%
Indian inst/Mut Fund 8.3%
FIIs 5.9%
ADR/GDR 0.0%
Free float 11.0%
Shareholders 44,069
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Zydus Tower, Satellite Cross Roads, Ahmedabad - 380 015
E-MAIL upen.shah@zyduscadila.com WEB www.zyduscadila.com
TELEPHONE (079) 2686 8326 FAX (079) 2686 2365
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Sharepro Serv.,416-420, Devnandan Mall, Ellisbridge, Ahmedabad-09
AUDITOR Mukesh M. Shah & Co.
CHM: Pankaj R. Patel (MD) COMP SEC: Upen H. Shah YEAR OF INC: 1995 BSE CODE: 532321 FV (Rs): 5 DIV YIELD (%): 1.0

Read: CADILA HEALTHCARE 2017-18 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   GLENMARK PHARMA  ELDER PHARMA  ALKEM LABORATORIES  J.B.CHEMICALS  FDC LTD.  

Compare CADILA HEALTHCARE With:   GLENMARK PHARMA  ELDER PHARMA  ALKEM LABORATORIES  J.B.CHEMICALS  FDC LTD.  

Compare CADILA HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 224 Points Higher; Realty and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended on a positive note.

Views on news

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

More Views on News

Most Popular

6 Charts Showing the State of Indian Financial Markets in 2020 (Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

This 'Essential Product' Smallcap is a Must Have for a 'Covid-19' Immune Portfolio (Profit Hunter)

May 19, 2020

This smallcap company needs no stimulus measures to do well in the long term.

What the RBI's Rate Cut Means for Options Traders (Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

Which Stocks Should You Buy, Sell, and Hold in the Market Today? (Profit Hunter)

May 21, 2020

The coronavirus led uncertainty refuses to go away from the markets. Here's what retail investors should do with their stocks...

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - TEVA PHARMA COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS